Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66308-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- CD27 antibody
- Antibody type
- Monoclonal
- Description
- CD27 antibody (Cat. #66308-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1C1G3
- Vial size
- 20ul, 150ul
Submitted references MIF-expressing tumor cells mediate immunotherapeutic resistance in esophageal squamous cell carcinoma.
Multiple circulating inflammatory proteins are associated with pathological lesions and kidney function decline in IgA nephropathy.
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma.
Song J, Song X, Xie Y, Guo H, Cun Y
Theranostics 2026;16(3):1613-1629
Theranostics 2026;16(3):1613-1629
Multiple circulating inflammatory proteins are associated with pathological lesions and kidney function decline in IgA nephropathy.
Kobayashi H, Murata Y, Akiya Y, Matsuoka T, Otsuka H, Tsunemi A, Nakamura Y, Azuma M, Abe M
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2025 Nov 6;74(1):160
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2025 Nov 6;74(1):160
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma.
Liu Y, Ye SY, He S, Chi DM, Wang XZ, Wen YF, Ma D, Nie RC, Xiang P, Zhou Y, Ruan ZH, Peng RJ, Luo CL, Wei PP, Lin GW, Zheng J, Cui Q, Cai MY, Yun JP, Dong J, Mai HQ, Xia X, Bei JX
Nature communications 2024 Sep 4;15(1):7713
Nature communications 2024 Sep 4;15(1):7713
No comments: Submit comment
No validations: Submit validation data